Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: A population-based case control study from the Nordic countries

Bone Marrow Transplantation

Volumn 23, Issue 6, 1999, Pages 555-560

  Schroeder, H ^a   Gustafsson, G ^b   Saarinen Pihkala, U M ^d   Glomstein, A ^c   Jonmundsson, G ^d   Nysom, K ^d   Ringden O ^b   Mellander, L ^e  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Lannspitalin ^*

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ALL; Allogeneic; BMT; Childhood; Second remission

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; HLA MATCHING; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; SCANDINAVIA; T CELL LEUKEMIA;

EID: 0033021499     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701617     Document Type: Article

References (31)

1. Rivera GK, Pinkel D, Simone JV et al. Treatment of acute lymphoblastic leukemia. 30 years' experience at St Jude Children's Research Hospital. New Engl J Med 1993; 329: 1289-1295.
2. Rivera GK, Buchanan G, Boyett JM et al. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. New Engl J Med 1986; 315: 273-278.
3. Chessels JM. Acute leukemia in children. Clin Haematol 1986; 15: 727-753.
4. Henze G, Fengler R, Hartmann R et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 1991; 78: 1166-1172.
5. Behrendt H, van Leeuwen EF, Schuwirt C et al. Bone marrow relapse occurring as first relapse in children with acute lymphoblastic leukemia. Med Ped Oncol 1990; 18: 190-196.
6. Bührer C, Hartman R, Fengler R et al. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Ped Oncol 1993; 21: 470-476.
7. Schroeder H, Garwicz S, Kristinsson J et al. Outcome after first relapse in children with acute lymphoblastic leukemia. A population based study of 315 patients from the Nordic Society of Pediatric Haematology and Oncology (NOPHO). Med Ped Oncol 1995; 25: 372-378.
8. Butturini A, Bortin MM, Rivera GK, Gale RP. Which treatment for childhood acute lymphoblastic leukemia in second remission? Lancet 1987; i: 429-432.
9. Roberts I. Bone marrow transplantation in children: current results and controversies. Bone Marrow Transplant 1994; 14: 197-199.
10. Brochstein JA, Kernan N, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. New Engl J Med 1987; 317: 1618-1624.
11. Kersey JH, Weisdorf D. Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. New Engl J Med 1987; 317: 461-467.
12. Ringdén O, Bolme P, Lönnqvist B et al. Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden. Ped Hematol Oncol 1989; 6: 137-144.
13. Dopfer R, Henze G, Bender-Götze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM-and CoALL-protocols: results of the German Cooperative Study. Blood 1991; 78: 2780-2784.
14. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. New Engl J Med 1994; 331: 1253-1258.
15. Ebell W, Reiter A, Riehm H. Chemotherapy versus bone marow transplantation in childhood acute lymphoblastic leukemia. Eur J Pediatr 1992; 151 (Suppl. 1): S50-S54.
16. Moussalem M, Bourdeau HE, Devergie A et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease. Bone Marrow Transplant 1995; 15: 943-947.
17. Schmid H, Linderkamp C, Hartmann R et al. Allogeneic BMT is superior to chemotherapy in early relapsed childhood ALL: results of four consecutive ALL-REZ BFM studies. Med Ped Oncol 1994; 23: 203 (Abstr.).
18. Graham-Pole J. Treating acute lymphoblastic leukemia after relapse: bone marrow transplantation or not. Lancet 1989; ii: 1517-1518.
19. UM Saarinen, L Mellander, K Nysom et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Bone Marrow Transplant 1996; 17: 357-363.
20. Gustafsson G, Garwicz S, Hertz H et al. A population based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Incidence, patient characteristics and treatment results. Acta Paediatr Scand 1987; 76: 781-788.
21. Riehm H, Gadner H, Henze G. Results and significance of six randomised trials in four consecutive ALL-BFM studies. Haematol Blood Transfus 1990; 33: 439-450.
22. Wollner N, Exelby PR, Lieberman P. Non Hodgkin lymphoma in children. Cancer 1979; 44: 1990-1999.
23. Henze G, Fengler R, Hartmann R et al. Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia. Cancer Chemother Pharmacol 1989; 24 (Suppl.): S16-S19.
24. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
25. Ringdén O, Bolme P, Lönnqvist B et al. Bone marrow transplantation in children. Clin Transplant 1989; 3: 12-18.
26. Ringdén O, Horowitz MM, Sondel P et al. Methotrexate, cyclosporine or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 1993; 81: 1094-1101.
27. Norusis MJ. SPSS Statistical Software. SPSS Inc: Chicago, IL, 1994.
28. Hoogerbrugge PM, Gerritsen EJA, vd Does-van den Berg A et al. Case-control analysis of allogeneic bone marrow transplantation vs maintenance chemotherapy for relapsed ALL in children. Bone Marrow Transplant 1995; 15: 255-259.
29. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. New Engl J Med 1979; 300: 1068-1073.
30. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions following bone marrow transplantation in humans. Blood 1989; 75: 555-562.
31. Ringdén O, Labopin M, Gluckman E et al. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Bone Marrow Transplant 1996; 18: 921-929.